Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $350 Price Target

Benzinga · 07/06 12:56
Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintains $350 price target.